Connect with us
In recent years, the healthcare industry has witnessed an explosion of startups promising innovative solutions to revolutionise patient care, improve accessibility, and reduce costs. However, amid...
Amid serious financial troubles, healthtech unicorn PharmEasy will raise INR 3,500 Cr through a rights issue next week to repay a large portion of its debt...
16th August,2023 – Drs.OnCalls, a leading US-based telemedicine platform, has announced the launch of its groundbreaking “Second Opinion Service” connecting patients with world-class doctors for expert...
If there is one thing besides the investor dry powder that has fuelled the growth of the world’s third-largest startup economy, it is, without a doubt,...
Healthtech unicorn Pristyn Care has commenced operations in Bangladesh, setting aside INR 100 Cr for the next two years of expansion in the neighbouring country. The...
In another trouble brewing for Pristyn Care, the healthtech startup has reportedly suspended the founders of Lybrate, a primary-care company it acquired last year. Sources told...
API Holdings, the parent company of debt-laden PharmEasy, has reportedly decided to raise funds through a rights issue. During an all-investor meeting held on Monday (July...
API Holdings, the parent entity of debt-laden PharmEasy, reportedly decided to raise INR 2,000 Cr-INR 3,000 Cr via a rights issue, during an all-investor meeting held...
Drs.OnCalls, a leading telemedicine platform based in the United States, has announced its strategic expansion into the Indian market. Having successfully established its presence in multiple...
Caught in the middle of multiple financial troubles, epharmacy giant PharmEasy has set in motion the process to raise additional capital from investors. The board of...
